N6-(Arylalkyl)adenosines. Identification of N6-(9-fluorenylmethyl)adenosine as a highly potent agonist for the adenosine A2 receptor
Several N6-(arylalkyl)adenosines related to N6-benzyladenosine were synthesized, and their A1 and A2 adenosine receptor binding affinities were determined. The annulated derivative N6-(1-naphthylmethyl)adenosine resulted in a very potent A2 agonist (A1 Ki = 24 nM, A2 Ki = 9.1 nM), whereas N6-(9-anth...
Saved in:
Published in | Journal of medicinal chemistry Vol. 31; no. 1; pp. 271 - 273 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
American Chemical Society
01.01.1988
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Several N6-(arylalkyl)adenosines related to N6-benzyladenosine were synthesized, and their A1 and A2 adenosine receptor binding affinities were determined. The annulated derivative N6-(1-naphthylmethyl)adenosine resulted in a very potent A2 agonist (A1 Ki = 24 nM, A2 Ki = 9.1 nM), whereas N6-(9-anthracenylmethyl)adenosine was virtually inactive (A1 Ki = 9,000 nM, A2 Ki = 29,000 nM). Interestingly, the structurally similar N6-(9-fluorenylmethyl)adenosine was the most potent A2 agonist reported to date, with a Ki of 4.9 nM in A2 binding and 5.1 nM in A1 binding. The homologues N6-9-fluorenyladenosine and N6-[2-(9-fluorenyl)ethyl]adenosine showed little or no activity at either adenosine receptor. Effects of these agents on heart rate and coronary flow in the isolated rat heart paralleled their A1 and A2 binding affinities, respectively. These data suggest that for high affinity at the A2 receptor a planar hydrophobic function at a certain distance and angle from the N6 nitrogen is required. |
---|---|
AbstractList | Several N6-(arylalkyl)adenosines related to N6-benzyladenosine were synthesized, and their A1 and A2 adenosine receptor binding affinities were determined. The annulated derivative N6-(1-naphthylmethyl)adenosine resulted in a very potent A2 agonist (A1 Ki = 24 nM, A2 Ki = 9.1 nM), whereas N6-(9-anthracenylmethyl)adenosine was virtually inactive (A1 Ki = 9,000 nM, A2 Ki = 29,000 nM). Interestingly, the structurally similar N6-(9-fluorenylmethyl)adenosine was the most potent A2 agonist reported to date, with a Ki of 4.9 nM in A2 binding and 5.1 nM in A1 binding. The homologues N6-9-fluorenyladenosine and N6-[2-(9-fluorenyl)ethyl]adenosine showed little or no activity at either adenosine receptor. Effects of these agents on heart rate and coronary flow in the isolated rat heart paralleled their A1 and A2 binding affinities, respectively. These data suggest that for high affinity at the A2 receptor a planar hydrophobic function at a certain distance and angle from the N6 nitrogen is required. |
Author | Haleen, S. J Trivedi, B. K Steffen, R. P Bruns, R. F Bristol, J. A |
Author_xml | – sequence: 1 givenname: B. K surname: Trivedi fullname: Trivedi, B. K – sequence: 2 givenname: J. A surname: Bristol fullname: Bristol, J. A – sequence: 3 givenname: R. F surname: Bruns fullname: Bruns, R. F – sequence: 4 givenname: S. J surname: Haleen fullname: Haleen, S. J – sequence: 5 givenname: R. P surname: Steffen fullname: Steffen, R. P |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7484828$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/3336027$$D View this record in MEDLINE/PubMed |
BookMark | eNpt0M9r2zAUB3AxOrq022nngQ5j6yju9MO2lGPourRQukLDruJZlhunspRKMsz3_eFTSQg97CTB9_Mej-8JOnLeGYQ-UnJBCaPfNwMhfF4DKcs3aEYrRopSkvIIzQhhrGA14-_QSYwbkh1l_Bgdc85rwsQM_b2ri7NFmCzYp8l-g9Y4H3tn4gW-yf_Ud72G1HuHfYdf7Lzo7OiDcZMdTFq_nsEQMeB1_7i2E976lMcxPHrXx4Q7H3BaZ3LAC4aD0WabfHiP3nZgo_mwf0_R6ufV6vK6uP21vLlc3BbAaZWKRlPJdVUL0xAiDasE0URrUc6rhpG2ldDWrSxhDi2roJO6ZaKUUHeioo0s-Sn6slu7Df55NDGpoY_aWAvO-DEqIQlnvKYZnu-gDj7GYDq1Df0AYVKUqJfK1avKs_60Xzs2g2kPdt9xzj_vc4gabBfA6T4eWD6xlExmVuxYrsv8OcQQnlQtuKjU6v5BLa-ZWP64_60esv-686Cj2vgxuFzdfw_8B_x3ptM |
CODEN | JMCMAR |
CitedBy_id | crossref_primary_10_1016_0031_6865_93_90012_U crossref_primary_10_1016_j_bmcl_2009_12_064 crossref_primary_10_1021_acs_jmedchem_2c01789 crossref_primary_10_1111_j_1476_5381_1993_tb13891_x crossref_primary_10_1021_jo071074x crossref_primary_10_1254_jjp_57_153 crossref_primary_10_3109_03639049109048085 crossref_primary_10_1111_j_1469_185X_1990_tb01240_x crossref_primary_10_1016_S0040_4020_01_80361_6 crossref_primary_10_1016_S0040_4039_00_99214_1 crossref_primary_10_1016_0922_4106_89_90041_2 crossref_primary_10_1016_0014_2999_91_90410_R crossref_primary_10_3109_03639049109048076 crossref_primary_10_1080_07328319008046066 crossref_primary_10_1111_j_1469_185X_1993_tb00997_x |
ContentType | Journal Article |
Copyright | 1988 INIST-CNRS |
Copyright_xml | – notice: 1988 INIST-CNRS |
DBID | BSCLL IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1021/jm00396a044 |
DatabaseName | Istex Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1520-4804 |
EndPage | 273 |
ExternalDocumentID | 10_1021_jm00396a044 3336027 7484828 ark_67375_TPS_GH27GDPV_S a481023595 |
Genre | Journal Article Comparative Study |
GroupedDBID | - 08R 1WB 3EH 53G 55 55A 5GY 5RE 5VS 9M8 AABXI ABFLS ABMVS ABOCM ABPTK ACGFS ACJ ACS AENEX AFFNX AGXLV AJYGW ALMA_UNASSIGNED_HOLDINGS ANTXH AQSVZ BAANH CS3 DU5 F5P GJ HR JG JG~ L7B LG6 MVM NHB OHT P2P RNS ROL TN5 W1F WH7 X X7M XFK YZZ ZE2 ZGI --- -~X .55 .GJ .HR .K2 6TJ ABHMW ABJNI ACGFO AEQTP AHGAQ BSCLL GGK IH2 VG9 XSW YQT 1KJ 3O- 4.4 6P2 7~N AAYOK ABDTD ABFRP ABQRX ABTAH ABUCX ADGIM ADHLV AEESW AFEFF EBS ED~ EJD GNL IH9 IHE IQODW UI2 VF5 ZY4 AAHBH CGR CUPRZ CUY CVF ECM EIF NPM UBC AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-a315t-bc183c567eb008e2570c0cc7495b20dd8ad6d84a9ad25af8cd2748a6f751b843 |
IEDL.DBID | ACS |
ISSN | 0022-2623 |
IngestDate | Fri Aug 16 23:10:23 EDT 2024 Fri Aug 23 02:53:13 EDT 2024 Sat Sep 28 08:33:49 EDT 2024 Fri Nov 25 13:53:06 EST 2022 Wed Jan 17 04:59:09 EST 2024 Thu Aug 27 13:42:28 EDT 2020 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Purine nucleoside Ribonucleoside Biological activity Biological receptor |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a315t-bc183c567eb008e2570c0cc7495b20dd8ad6d84a9ad25af8cd2748a6f751b843 |
Notes | ark:/67375/TPS-GH27GDPV-S istex:D6F43B6CF72704061D8BC84787D8926CA560E549 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 3336027 |
PQID | 78032361 |
PQPubID | 23479 |
PageCount | 3 |
ParticipantIDs | proquest_miscellaneous_78032361 crossref_primary_10_1021_jm00396a044 pubmed_primary_3336027 pascalfrancis_primary_7484828 istex_primary_ark_67375_TPS_GH27GDPV_S acs_journals_10_1021_jm00396a044 |
ProviderPackageCode | JG~ 55A AABXI ACS ACJ AGXLV ABMVS 1WB BAANH AQSVZ W1F ANTXH |
PublicationCentury | 1900 |
PublicationDate | 19880101 1988-01-01 1988 1988-Jan 1988-01-00 |
PublicationDateYYYYMMDD | 1988-01-01 |
PublicationDate_xml | – month: 01 year: 1988 text: 19880101 day: 1 |
PublicationDecade | 1980 |
PublicationPlace | Washington, DC |
PublicationPlace_xml | – name: Washington, DC – name: United States |
PublicationTitle | Journal of medicinal chemistry |
PublicationTitleAlternate | J. Med. Chem |
PublicationYear | 1988 |
Publisher | American Chemical Society |
Publisher_xml | – name: American Chemical Society |
SSID | ssj0003123 |
Score | 1.4375314 |
Snippet | Several N6-(arylalkyl)adenosines related to N6-benzyladenosine were synthesized, and their A1 and A2 adenosine receptor binding affinities were determined. The... |
SourceID | proquest crossref pubmed pascalfrancis istex acs |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 271 |
SubjectTerms | Adenosine - analogs & derivatives Adenosine - chemical synthesis Adenosine - metabolism Animals Brain - metabolism Carbohydrates. Nucleosides and nucleotides Cell Membrane - metabolism Chemistry Coronary Circulation - drug effects Exact sciences and technology Fluorenes - chemical synthesis Fluorenes - metabolism Heart Rate - drug effects In Vitro Techniques Indicators and Reagents Kinetics Nucleosides, nucleotides and oligonucleotides Organic chemistry Preparations and properties Rats Receptors, Purinergic - metabolism Structure-Activity Relationship |
Title | N6-(Arylalkyl)adenosines. Identification of N6-(9-fluorenylmethyl)adenosine as a highly potent agonist for the adenosine A2 receptor |
URI | http://dx.doi.org/10.1021/jm00396a044 https://api.istex.fr/ark:/67375/TPS-GH27GDPV-S/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/3336027 https://search.proquest.com/docview/78032361 |
Volume | 31 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lj9MwELZg9wAXHgsrsrDgw6oCaVMSO7GdY1XoVkisKrWgvUWTxEGiIamSVNpw5oczbpKGXV53z8H253l4Zr4h5EyxCK0aBjlMB8z20EW3FXjcTn3JmfaV1J7pHf54KeafvA9X_tVQRHM7g8_ct1-_mf5RAY7n3SWHDC2iibEm0-Ve4XKX8Z4UnKE579rwbgkb8xNXN8zPoTnJa1MOCRWeSNqOsvi7r7mzObOHZNZ37rSlJuvxto7G8fffiRz_vZ1H5EHnddJJC5PH5I7Oj8i9aT_s7YiMFi2FdXNOV0NHVnVOR3QxkFs3T8iPS2G_npRNBtm6yd5AYsjGTen8mLY9v2n3CUiLlJq1gZ1m26LUeZOZadW_ylCoKFBDmJw1dFOg915T-FIYLl-KvjRF35QOiyeMonbWm7oon5LV7P1qOre7SQ42cNev7ShGzRH7QppJRUqbyXmxE8cSo7OIOUmiIBGJ8iCAhPmQqjjBYFmBSKXvIpb4MTnIi1w_I1TFAY_BkTIwOWZUHpJzSAUAF4hFoSxC8ZbD7iFW4S7HzjDGGY7dImc9BMJNS-nx52WjHTz2a6Bcmyo46YerxTK8mDN58W7xOVxa5PQGfvYChqYVA1qLvOrxFOKtmoQM5LrYVqFUDjfkNxY5bmG2F-WcC4fJk__v5jm57wZKtb9CL8hBXW71KfpJdfRy90p-Ai6hCdg |
link.rule.ids | 315,786,790,2782,4043,27107,27954,27955,27956,57091,57141 |
linkProvider | American Chemical Society |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwED-N7WG88DGY6GDMD1MFUtMldmI7j1VhK7BWlVrQ3iLHcZBo1lRNKhGe-cM5J_1gEwje7yL7cr4P--53AOeSxujVMMmhJqSOjyG6I5XPnDQQjJpACuPb3uHhiA8--x9vgps96Gx6YXARBX6pqB_xd-gC3sW3W9tGypXr-w_gIBDo52wg1J9s7S7zKNtgg1P06utuvHvM1gvp4o4XOrAC_W6rIlWBgkmbiRZ_Dzlr13P5GIbbRdcVJ7Puqoy7-sc9PMf_3dUTeLSOQUmvUZqnsGfmR3DY34x-O4L2uAG0rjpkuuvPKjqkTcY7qOvqGfwccedNb1llKptV2VuVWOhxW0jfJU0HcLq-EiR5Sixt6KTZKl-aeZXZ2dW_8xBVEEUsfHJWkUWOsXxJ1NfcIvsSjKwJRqpkR9yjBG21WZT58jlML99P-wNnPdfBUcwLSifWaEd0wIWdWySNnaOnXa0F5moxdZNEqoQn0lehSmigUqkTTJ2l4qkIPNQsdgz783xuXgCROmRauUKE9sUZTYlgTKVcKcZRM7lsAUGpR-tjWUT1izvFjGcn9hacbzQhWjQAH38ma9dasqVRy5mtiRNBNB1PoqsBFVfvxl-iSQtO76jRlsGCtmJ624KzjVpF-Fft84yam3xVREK6zELhtOC40bYtK2OMu1Sc_Hs3Z3A4mA6vo-sPo08v4aEXStncF72C_XK5MqcYQZXx6_rg_AJ_7hJD |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFD4amwS8cBlMBBjzw1SBtHSJncTOY9XRlVsV1IL2Fjk3JBqSKkklwjM_nOPcyiYQ4t2ObOc7N_uc7wCcChqgVcMgh8Yu1S100XUhLaYnNmc0tgWPLVU7_GHhzD9Zb6_sqz0w-loYXESJXyqbR3wl1Zso6RgGzPOv31QpqSMNy7oFBzY3LSWKk-ly0L3MpKznB6do2buKvBuTlSUKy2uW6EAd6neVGSlLPJyk7Wrxd7ezMT-z-_BxWHiTdbIeb6tgHP64wen4Pzt7APc6X5RMWvA8hL04O4Q7074F3CGMvJbYuj4jq12dVnlGRsTbUV7Xj-DnwtFfToo6lem6Tl_JSFGQq4T6MWkrgZPuapDkCVFjXT1Jt3kRZ3Wqelj_PofIkkiiaJTTmmxy9OkrIr_kiuGXoIdN0GMlu8ETSlBnx5sqLx7DavZ6NZ3rXX8HXTLTrvQgRH0S2g5X_YtErPrphUYYcozZAmpEkZCREwlLujKitkxEGGEILaSTcNtEhLEj2M_yLH4CRIQuC6XBuatenlGlcMZk4kjJHESoIzQgePJ-J56l37y8U4x8dseuwWmPBn_TEn38edioQcowRhZrlRvHbX_lLf3LOeWXF95nf6nB8TUoDRMUeSuGuRqc9NDy8a-qZxqZxfm29LkwmKLE0eCoRdwwlTHmGJQ__fduTuC2dzHz379ZvHsGd01XiPba6DnsV8U2PkZHqgpeNLLzC0wcFL0 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=N6-%28arylalkyl%29adenosines.+Identification+of+N6-%289-fluorenylmethyl%29adenosine+as+a+highly+potent+agonist+for+the+adenosine+A2+receptor&rft.jtitle=Journal+of+medicinal+chemistry&rft.au=TRIVEDI%2C+B.+K&rft.au=BRISTOL%2C+J.+A&rft.au=BRUNS%2C+R.+F&rft.au=HALEEN%2C+S.+J&rft.date=1988&rft.pub=American+Chemical+Society&rft.issn=0022-2623&rft.eissn=1520-4804&rft.volume=31&rft.issue=1&rft.spage=271&rft.epage=273&rft_id=info:doi/10.1021%2Fjm00396a044&rft.externalDBID=n%2Fa&rft.externalDocID=7484828 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2623&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2623&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2623&client=summon |